Daewoong Pharmaceutical Co., Ltd.
Nabota 200 Units
Invest in more volume to cover more treatment areas with Nabota, which contains 200 units per vial! Nabota, developed by Daewoong Pharmaceutical Co. in South Korea, uses the purest types of botulinum toxin for muscle relaxation, resulting in fewer wrinkles and facial lines.
It is available in 1 x 200U/vial.
Product Description
About Nabota 200 Units
Nabota 200 Units has twice the capacity of Nabota 100U and delivers the same ultra-pure, FDA-approved neurotoxin in a bigger dose size, making it perfect for advanced aesthetic practitioners. This variant is commonly used for full-face neuromodulation, treatment of masseter hypertrophy, trapezius slimming, and body Botox regimens. Because Nabota maintains potency across dilution ranges, doctors can administer large-area injections efficiently and safely.
Daewoong Pharma created Nabota using cutting-edge technology, leveraging its 30-year bio-product experience and proprietary manufacturing techniques. As a result, the Nabota 200 Units, introduced in 2015, contain the purest botulinum toxin type A. Following the revolutionary Nabota 100U, Daewoong expanded the dosing possibilities by introducing the 50U and 200U versions in the same year to make it easier for both doctors and patients.
Nabota 200 Units is a high-purity product manufactured using Daewoong's exclusive purification technology. This ensures that Nabota is both safe and effective as a Botox alternative. Furthermore, after a few weeks of treatment, Nabota 200 units demonstrates rapid improvement in the eradication of glabella lines. The initial symptoms do not appear until two days after injection. Patients are delighted after completing treatment sessions with Nabota, displaying superior results when compared to other brands. Patients do not acquire tolerance to Nabota after four months of treatment, even when given low doses of 20 units. Overall, Nabota 200U significantly improves skin by reducing aging-related skin disorders such as deep frown lines, eye wrinkles (crow's feet), and facial contouring.
Why Choose This Product
Key Benefits of Nabota 200 Units
- A larger capacity formulation especially designed for multiple use in clinics and by doctors
- Offers excellent stability after dilution
- Corrects deep wrinkles in the facial area, which includes glabellar lines and nasolabial folds
- It is FDA-certified for its safety and performance as an anti-aging solution
- A highly purified product manufactured with an innovative purification process from which impurities are completely removed to guarantee a safe injection into the body
- Improves hyperhidrosis, particularly on the palms and soles of the feet
- Treats blepharospasm, which is the involuntary blinking or twitching of the eyelids
- Improves wrinkles surrounding the periorbital and perioral areas
- Because of its quality and excellence, Nabota has secured contracts to export its final products to over 90 countries globally
Treatment Areas
Scope of Application
Jawline slimming
Shoulder (trapezius) contouring
Neck rejuvenation
Calf reduction
Full-face wrinkle management
Glabellar frown lines
Hyperhidrosis in the palms, thighs, and armpits
Results Timeline
Duration of Effect
In most cases, the initial effect occurs 1-3 days following the treatment session with Nabota, with the complete results peaking one to two weeks later. The results last for at least four months.
Composition
Product Composition
Nabota contains 200 U of Clostridium botulinum toxin type A and is formulated with 0.5mg human serum albumin, a stabilizer, and 0.9mg sodium chloride as a tonicity adjuster.
Technical Details
Specifications of Nabota 200 Units
| Packaging | 1 x 200U vial |
|---|---|
| Composition | 200U Clostridium Botulinum Toxin Type A, 0.5mg Human serum albumin, 0.9mg Sodium chloride |
| Cannula size | 27G~30G |
| Injection depth | Intramuscular |
| Treatment areas | Eyelids (blepharospasm), glabella/frown lines, calf muscles, forehead, palms, and soles of the feet |
| Recommended dosage | Using a sterile 30G needle, administer 0.1 mL to each of the five injection sites, two in each corrugator muscle and one in the procerus muscle, for a total dose of 20 units for treating prominent glabella lines with Nabota 200 Units. |
| Treatment interval | Limit the maintenance treatment sessions to only 3 months after the initial procedure. Frequent treatment sessions are to prevent tolerance to the product and overdosage. |
| Duration of effect | 6~8 months |
| Storage | Store at 2 to 8℃ or refrigerated in its hermetic container. |
| Shelf life | 36 months from manufacturing date |
| Manufacturer | Daewoong Pharmaceutical Co., Ltd. |
Source Nabota 200 Units
Ready to Order Nabota 200 Units?
Connect with our team to request pricing, availability, and wholesale sourcing information for Nabota 200 Units and our full range of premium Korean botulinum toxin products.